New Product Or Brand Launch
Expected: 9-month periodMEDIUM confidence
What: Product Count: 3 products
“In 9-month period, we have launched one is Dinkar, one is Melody and one is Verdour.”
Dhanuka Agritech Ltd: Stock Analysis & Fundamentals
Data from 2w agoDhanuka Agritech Ltd (Pesticides/Agrochemicals) — fundamental analysis, earnings data, and key metrics. PE: 16.5. ROE: 22.0%. This stock is not currently in the Nifty 500 momentum outperformers list.
Dhanuka Agritech Ltd Key Facts
What's Happening
💪Debt reduced 57% YoY — balance sheet strengthening
👔Promoter stake down 0.6% this quarter
Earnings Acceleration Triggers
1. New Product Or Brand Launch
9-month periodMEDIUM
2. Operating Leverage Inflection
FY27MEDIUM
3. Regulatory Approval Or License Win
Q1 FY27MEDIUM
Key Risks
1. Significantly extended rainfall and potential El Nino impact on Kharif season
HIGH2. Ban on biostimulants led to a ₹49 Cr impact on 9-month sales
MEDIUM3. China ending export rebates on technicals may increase prices
LOWSector-Specific Signals
Herbicides % of Turnover37%
South India Revenue Share34%
Sales Returns (Q3)₹72 Cr-₹2 Cr
Biostimulant Regulatory Impact (9M)₹49 Cr
Key Numbers
Current Price
₹1,067
Dividend Yield
0.19%
Market Cap
4.8K Cr
Valuation
N/AWhy Are Dhanuka Agritech Ltd's Earnings Accelerating?
Based on Q3 FY26 earnings • Updated Apr 18, 2026
Operating Leverage Inflection
Expected: FY27MEDIUM confidence
What: Capacity Utilization: 80%
Impact: EBITDA Positive
“Definitely, there would be an improvement in the margin structure for the products once the manufacturing moves to India, absolutely.”
Regulatory Approval Or License Win
Expected: Q1 FY27MEDIUM confidence
What: Product Approvals: 3 products
“But yes, we are tracking our approvals and we are hopeful of getting out of our, at least 3 products approval in this quarter, so that we can launch by Q1 ending.”
What Are the Key Risks for Dhanuka Agritech Ltd?
Earnings deceleration risks from management commentary
Significantly extended rainfall and potential El Nino impact on Kharif season
HIGHTrigger: Weather patterns delayed harvesting and reduced agrochemical application.
Management view: Monitoring IMD forecasts; focusing on Rabi season recovery.
Monitor: climate
Ban on biostimulants led to a ₹49 Cr impact on 9-month sales
MEDIUMTrigger: New government guidelines required fresh clearances for biostimulant products.
Impact: PAT impact: ₹49 Cr revenue hit
Management view: Applied for proprietary clearances; expecting 3 approvals by Q4 end.
Monitor: regulatory
China ending export rebates on technicals may increase prices
LOWTrigger: Internal approach by China to reduce export incentives.
Management view: Passing on increased costs downstream; sourcing some products like Glufosinate from India.
Monitor: commodity
What Is Dhanuka Agritech Ltd's Management Saying?
Key quotes from recent conference calls
“So, first question, I think, on the PPT, you have mentioned that you're expecting a flattish revenue performance in FY '26. [Previous Revenue Growth guidance]”
“We are working for making Dahej operations EBITDA positive in FY'27 and try to reach 80% capacity utilization of the existing plant. [Initiative: Dahej Plant Scale-up]”
“Indian farmers delayed purchases due to significantly extended rainfall and weaker commodity realizations. [Risk (climate): HIGH]”
“Product under regulatory changes in this category... 9 month is the impact of Rs. 49 crore on account of these four products biostimulant stock sale basically. [Risk (regulatory): MEDIUM]”
What Did Dhanuka Agritech Ltd Report This Quarter?
Headline numbers from the latest earnings call
Revenue
₹409.92 Cr
YoY -7.9%QoQ -31.5%
Why: Agrochemical demand remained weak due to stressed demand drivers, weather issues, and low crop prices leading to industry-wide volume decline.
Revenue was significantly impacted by sharp demand declines in South and West India.
EBITDA
₹58.66 Cr
YoY -22.4%Margin 14.3%
Why: The decline was driven by lower top-line realizations and the impact of two straight negative quarters.
Margins were pressured by weak demand and extended rainfall delaying farmer purchases.
PAT
₹40 Cr
YoY -27.3%QoQ -57.4%
Why: Lower farm incomes reduced spending on crop production products, impacting domestic sales and overall profitability.
Management described the two straight negative quarters as a blemish on an otherwise decent performance.
Other Highlights
• Commercialized second product from Dahej plant in Q3 FY'26.
• Net economic benefit from Bayer molecules was ₹6 Cr in Q3.
• Cash on books and liquid investments exceed ₹250 Cr.
What Sector Metrics Matter for Dhanuka Agritech Ltd?
Sub-sector-specific signals from the latest concall — each with management's stated reason for the change
Herbicides % of Turnover
37%
QoQ +2800 bps
Why: Herbicides share increased significantly in Q3 compared to 9% in Q2.
South India Revenue Share
34%
QoQ +100 bps
Why: South India remains the largest contributing zone despite sharp demand declines.
Sales Returns (Q3)
₹72 Cr
YoY -₹2 Cr
Why: Returns were similar to last year's ₹74 Cr, primarily in the herbicide segment due to rains.
Biostimulant Regulatory Impact (9M)
₹49 Cr
Why: Regulatory changes forced a halt in sales of four biostimulant products.
Dahej Plant Revenue (Q3)
₹4 Cr
QoQ -₹18 Cr
Why: Q3 is off-season for Bifenthrin and Difenoconazole production was delayed.
Bayer Molecule Revenue (9M)
₹25-27 Cr
Why: Revenue from acquired Bayer molecules currently appearing in Dhanuka's balance sheet.
Technical Sales (Q3)
₹3-4 Cr
Why: Technical sales are not significant in the third quarter.
Cash & Liquid Investments
₹250 Cr
Why: Maintained a strong debt-free balance sheet.
What Is Dhanuka Agritech Ltd's Management Guidance?
Forward-looking targets from management for FY26
OPM Guidance
24–25%
Capex Plan
₹70 Cr
Revenue Outlook
Flattish for FY26
Margin Outlook
REAFFIRMED
Capex Plan
₹60-70 Cr
MPP-2 plant construction
Management Tone: CAUTIOUS
Guidance Changes
LOWERED
Bayer Product Revenue: ₹40 Cr → ₹30 Cr
The above analysis is parsed from publicly available earnings call transcripts. This is educational research only — not investment advice. Last updated Apr 18, 2026.
Other Top Pesticides/Agrochemicals Stocks Beating Nifty 500
Frequently Asked Questions: Dhanuka Agritech Ltd
Based on publicly available financial data. This is educational research, not investment advice.
What were Dhanuka Agritech Ltd's latest quarterly results?
Dhanuka Agritech Ltd's latest quarterly results (Dec 2025) show
- PAT Growth YoY: -27.3%
- Revenue Growth YoY: -7.9%
- Operating Margin: 14.0%
What is Dhanuka Agritech Ltd's current PE ratio?
Dhanuka Agritech Ltd's current PE ratio is 16.5x.
- Current PE: 16.5x
- Market Cap: 4.8K Cr
- Dividend Yield: 0.19%
What is Dhanuka Agritech Ltd's price-to-book ratio?
Dhanuka Agritech Ltd's price-to-book ratio is 3.4x.
- Price-to-Book (P/B): 3.4x
- Book Value per Share: ₹311
- Current Price: ₹1067
Is Dhanuka Agritech Ltd a fundamentally strong company?
Dhanuka Agritech Ltd's fundamental strength based on key financial ratios
- Return on Capital (ROCE): 28.0%
Is Dhanuka Agritech Ltd debt free?
Dhanuka Agritech Ltd has a debt-to-equity ratio of N/A.
- Total Debt: ₹32 Cr
What is Dhanuka Agritech Ltd's return on equity (ROE) and ROCE?
Dhanuka Agritech Ltd's return ratios over recent years
- FY2023: ROCE 27.0%
- FY2024: ROCE 27.0%
- FY2025: ROCE 28.0%
Is Dhanuka Agritech Ltd's cash flow positive?
Dhanuka Agritech Ltd's operating cash flow is positive (FY2025).
- Cash from Operations (CFO): ₹263 Cr
- Free Cash Flow (FCF): ₹120 Cr
- CFO/PAT Ratio: 89% (strong cash conversion)
What is Dhanuka Agritech Ltd's dividend yield?
Dhanuka Agritech Ltd's current dividend yield is 0.19%.
- Dividend Yield: 0.19%
- Current Price: ₹1067
Who holds Dhanuka Agritech Ltd shares — promoters, FII, DII?
Dhanuka Agritech Ltd's shareholding pattern (Mar 2026)
- Promoters: 69.7%
- FII (Foreign): 1.9%
- DII (Domestic): 19.4%
- Public: 8.9%
Is promoter holding increasing or decreasing in Dhanuka Agritech Ltd?
Dhanuka Agritech Ltd's promoter holding has remained stable recently.
- Current Promoter Holding: 69.7% (Mar 2026)
- Previous Quarter: 69.7% (Dec 2025)
- Change: 0.00% (stable)
Is Dhanuka Agritech Ltd a new momentum entry or an established outperformer?
Dhanuka Agritech Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.
What are the growth catalysts for Dhanuka Agritech Ltd?
Dhanuka Agritech Ltd has 3 key growth catalysts identified from recent earnings analysis
- New Product Or Brand Launch — Introduction of Dinkar, Melody, and Verdour to drive market share.
- Operating Leverage Inflection — Moving manufacturing to India will improve margin structures.
- Regulatory Approval Or License Win — New regulatory framework for biostimulants favors organized players.
What are the key risks in Dhanuka Agritech Ltd?
Dhanuka Agritech Ltd has 3 key risks worth monitoring
- [HIGH] Significantly extended rainfall and potential El Nino impact on Kharif season — Weather patterns delayed harvesting and reduced agrochemical application.
- [MEDIUM] Ban on biostimulants led to a ₹49 Cr impact on 9-month sales — New government guidelines required fresh clearances for biostimulant products.
- [LOW] China ending export rebates on technicals may increase prices — Internal approach by China to reduce export incentives.
What did Dhanuka Agritech Ltd's management say in the latest earnings call?
In Q3 FY26, Dhanuka Agritech Ltd's management highlighted
- "So, first question, I think, on the PPT, you have mentioned that you're expecting a flattish revenue performance in FY '26. [Previous Revenue Growth ..."
- "We are working for making Dahej operations EBITDA positive in FY'27 and try to reach 80% capacity utilization of the existing plant. [Initiative: Dah..."
- "Indian farmers delayed purchases due to significantly extended rainfall and weaker commodity realizations. [Risk (climate): HIGH]"
What is Dhanuka Agritech Ltd's management guidance for growth?
Dhanuka Agritech Ltd's management has provided the following forward guidance for FY26
- Revenue outlook: Flattish for FY26
- OPM guidance: 24–25%
- Capex plan: ₹70 Cr for MPP-2 plant construction
- Management tone: cautious
- Milestone: [LOWERED] Bayer Product Revenue: ₹40 Cr → ₹30 Cr
What sector-specific metrics matter most for Dhanuka Agritech Ltd?
Dhanuka Agritech Ltd's most important sub-sector-specific KPIs from the latest concall
- Herbicides % of Turnover: 37% (QoQ +2800 bps) — Herbicides share increased significantly in Q3 compared to 9% in Q2.
- South India Revenue Share: 34% (QoQ +100 bps) — South India remains the largest contributing zone despite sharp demand declines.
- Sales Returns (Q3): ₹72 Cr (YoY -₹2 Cr) — Returns were similar to last year's ₹74 Cr, primarily in the herbicide segment due to rains.
- Biostimulant Regulatory Impact (9M): ₹49 Cr — Regulatory changes forced a halt in sales of four biostimulant products.
- Dahej Plant Revenue (Q3): ₹4 Cr (QoQ -₹18 Cr) — Q3 is off-season for Bifenthrin and Difenoconazole production was delayed.
- Bayer Molecule Revenue (9M): ₹25-27 Cr — Revenue from acquired Bayer molecules currently appearing in Dhanuka's balance sheet.
Is Dhanuka Agritech Ltd worth studying for long term investment?
Based on quantitative research signals, here is why Dhanuka Agritech Ltd may be worth studying
- Cash flow is positive — CFO ₹263 Cr
What is the investment thesis for Dhanuka Agritech Ltd?
Dhanuka Agritech Ltd investment thesis summary:
Research Signals (Bull Case)
- Growth catalyst: New Product Or Brand Launch
Risk Factors (Bear Case)
- Key risk: Significantly extended rainfall and potential El Nino impact on Kharif season
What is the future outlook for Dhanuka Agritech Ltd?
Dhanuka Agritech Ltd's forward outlook based on current data signals
- Key Catalyst: New Product Or Brand Launch
- Key Risk: Significantly extended rainfall and potential El Nino impact on Kharif season
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.